These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2848561)

  • 1. Heparin neutralization of antiplatelet effect of aspirin and dipyridamole.
    Mohammad SF; Kim SW; Olsen DB
    ASAIO Trans; 1988; 34(3):322-7. PubMed ID: 2848561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dipyridamole potentiates the inhibition of platelet aggregation by aspirin (in human platelet rich plasma and whole blood).
    Violi F; Praticò D; Iuliano L; Balsano F
    J Lipid Mediat; 1991; 4(1):61-7. PubMed ID: 1909906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of prostacyclin in vascular tissue.
    Moncada S; Vane JR
    Fed Proc; 1979 Jan; 38(1):66-71. PubMed ID: 215463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of low dose aspirin on platelet function in patients with recent cerebral ischemia.
    Weksler BB; Kent JL; Rudolph D; Scherer PB; Levy DE
    Stroke; 1985; 16(1):5-9. PubMed ID: 3966266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of preoperative antiplatelet drugs on vascular prostacyclin synthesis.
    Karwande SV; Weksler BB; Gay WA; Subramanian VA
    Ann Thorac Surg; 1987 Mar; 43(3):318-22. PubMed ID: 3548616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proceedings: Response of normal and pathological platelets to heparin added in vitrio and in vivo.
    David JL; Herion FP
    Thromb Diath Haemorrh; 1975 Sep; 34(1):341. PubMed ID: 1188778
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of antiplatelet therapy on platelet accumulation after experimental angioplasty in the rabbit iliac model.
    Faxon DP; Balelli LA; Sandborn T; Haudenschild C; Valeri R; Ryan TJ
    Int J Cardiol; 1992 Jul; 36(1):41-7. PubMed ID: 1428251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dipyridamole: pharmacokinetics and effects on aspects of platelet function in man.
    Gregov D; Jenkins A; Duncan E; Siebert D; Rodgers S; Duncan B; Bochner F; Lloyd J
    Br J Clin Pharmacol; 1987 Oct; 24(4):425-34. PubMed ID: 2825745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different effects of aspirin, dipyridamole and UD-CG 115 on platelet activation in a model of vascular injury: studies with extracellular matrix covered with endothelial cells.
    Eldor A; Vlodavsky I; Fuks Z; Muller TH; Eisert WG
    Thromb Haemost; 1986 Dec; 56(3):333-9. PubMed ID: 3551181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin inhibits the formation of endoperoxide metabolites in rat platelets: aspirin-like activity.
    Hwang DH; LeBlanc P
    Prostaglandins Med; 1981 Apr; 6(4):341-4. PubMed ID: 7280114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effect of platelet inhibitors in normal and in hypercholesterolaemic subjects.
    Aviram M; Winterstein G; Brook JG
    Br J Clin Pharmacol; 1985 Jun; 19(6):715-9. PubMed ID: 2992558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of ethanol, prostacyclin, and aspirin in determining human platelet reactivity in vitro.
    Jakubowski JA; Vaillancourt R; Deykin D
    Arteriosclerosis; 1988; 8(4):436-41. PubMed ID: 2840054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid platelet inhibition after a single capsule of Aggrenox: challenging a conventional full-dose aspirin antiplatelet advantage?
    Serebruany VL; Malinin AI; Sane DC
    Am J Hematol; 2003 Apr; 72(4):280-1. PubMed ID: 12666142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of platelet-modifying drugs on arterial thromboembolism in baboons. Aspirin potentiates the antithrombotic actions of dipyridamole and sulfinpyrazone by mechanism(s) independent of platelet cyclooxygenase inhibition.
    Hanson SR; Harker LA; Bjornsson TD
    J Clin Invest; 1985 May; 75(5):1591-9. PubMed ID: 3923041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are agents affecting platelet functions clinically useful?
    Verstraete M
    Am J Med; 1976 Dec; 61(6):897-914. PubMed ID: 795299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspirin and other platelet-aggregation inhibiting drugs.
    Gallus AS
    Med J Aust; 1985 Jan; 142(1):41-7. PubMed ID: 3880861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiplatelet therapy.
    Sloan RW
    Am Fam Physician; 1981 Oct; 24(4):129-34. PubMed ID: 7025599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin-induced thrombocytopenia: effect of heparin platelet antibody on platelets.
    Chong BH; Grace CS; Rozenberg MC
    Br J Haematol; 1981 Dec; 49(4):531-40. PubMed ID: 7317283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of ex vivo high on-treatment platelet reactivity on antiplatelet therapy after transient ischemic attack or ischemic stroke on the PFA-100(®) and VerifyNow(®).
    Kinsella JA; Tobin WO; Cox D; Coughlan T; Collins R; O'Neill D; Murphy RP; McCabe DJ
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):e84-92. PubMed ID: 22981273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does the association dipyridamole-aspirin only act by a functional synergism?
    De la Cruz JP; Sanchez de la Cuesta F
    Gen Pharmacol; 1991; 22(2):271-4. PubMed ID: 2055420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.